GAMCO Investors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,626
| Closed | -$618K | – | 874 |
|
|
2020
Q1 | $618K | Hold |
13,626
| – | – | 0.01% | 628 |
|
|
2019
Q4 | $886K | Hold |
13,626
| – | – | 0.01% | 638 |
|
|
2019
Q3 | $846K | Hold |
13,626
| – | – | 0.01% | 633 |
|
|
2019
Q2 | $970K | Hold |
13,626
| – | – | 0.01% | 612 |
|
|
2019
Q1 | $1.07M | Buy |
13,626
+4,008
| +42% | +$314K | 0.01% | 567 |
|
|
2018
Q4 | $814K | Buy |
9,618
+4,809
| +100% | +$407K | 0.01% | 572 |
|
|
2018
Q3 | $823K | Hold |
4,809
| – | – | 0.01% | 604 |
|
|
2018
Q2 | $622K | Sell |
4,809
-4,809
| -50% | -$622K | ﹤0.01% | 653 |
|
|
2018
Q1 | $991K | Hold |
9,618
| – | – | 0.01% | 559 |
|
|
2017
Q4 | $822K | Buy |
9,618
+1,603
| +20% | +$137K | 0.01% | 604 |
|
|
2017
Q3 | $681K | Hold |
8,015
| – | – | ﹤0.01% | 634 |
|
|
2017
Q2 | $607K | Hold |
8,015
| – | – | ﹤0.01% | 660 |
|
|
2017
Q1 | $529K | Buy |
+8,015
| New | +$529K | ﹤0.01% | 674 |
|